Stevanato Group S.p.A (STVN) Net Cash Flow Growth (3y) (2023 - 2026)
Stevanato Group S.p.A (STVN) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 124.86 Bn | 119.64 Bn | 1.96 Bn | -16.59% |
| 2 | Becton Dickinson | 44.42 Bn | 43.60 Bn | 2.15 Bn | -55.30% |
| 3 | Alcon | 33.14 Bn | 31.48 Bn | 1.53 Bn | 39.87% |
| 4 | Medline | 32.66 Bn | 30.42 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.13 Bn | 27.47 Bn | 890.98 Mn | 126.35% |
| 6 | West Pharmaceutical Services | 23.50 Bn | 23.06 Bn | 329.20 Mn | 2.16% |
| 7 | Solventum | 13.88 Bn | 13.32 Bn | 1.10 Bn | -159.90% |
| 8 | Cooper Companies | 13.84 Bn | 13.70 Bn | 735.40 Mn | 78.59% |
| 9 | Align Technology | 12.13 Bn | 11.07 Bn | 736.59 Mn | 36.49% |
| 10 | Stevanato Group S.p.A | 5.35 Bn | 5.21 Bn | 88.01 Mn | 32.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.34% |
| Dec 31, 2025 | 39.21% |
| Sep 30, 2025 | 33.42% |
| Jun 30, 2025 | 28.64% |
| Mar 31, 2025 | 48.89% |
| Dec 31, 2024 | 43.80% |
| Sep 30, 2024 | -92.76% |
| Jun 30, 2024 | -89.51% |
| Mar 31, 2024 | 69.69% |
| Dec 31, 2023 | 21.85% |
| Sep 30, 2023 | -31.28% |
| Jun 30, 2023 | -52.35% |